	Beneficio Bruto En Ventas		Fecha
Agilent	USD 990M	102M	2025-09
Bio Techne	USD 191.28M	3.16M	2025-12
Bio-Rad Laboratories	USD 343.4M	1.9M	2025-09
Boston Scientific	USD 3.68B	136M	2025-12
Bruker	USD 449.2M	69.8M	2025-12
Charles River Laboratories	USD 271.96M	39.43M	2025-12
Danaher	USD 3.97B	443M	2025-12
Dentsply International	USD 441M	49M	2025-09
Edwards Lifesciences	USD 1.23B	18.7M	2025-12
Exact Sciences	USD 583.93M	21.48M	2025-09
Hologic	USD 586.4M	2.9M	2025-12
Illumina	USD 759M	26M	2025-12
Intuitive Surgical	USD 1.9B	241.9M	2025-12
IQVIA Holdings	USD 1.12B	32M	2025-12
Laboratory Of America	USD 993.2M	31.9M	2025-12
Mettler Toledo International	USD 675.44M	65.98M	2025-12
Myriad Genetics	USD 143.8M	8M	2025-09
OraSure Technologies	USD 17.07M	7.62M	2024-09
Pacific Biosciences Of California	USD 10M	4.07M	2024-09
Quest Diagnostics	USD 873M	37M	2025-12
Quidel	USD 274.8M	1.01B	2025-12
Repligen	USD 100.52M	9.37M	2025-09
Revvity	USD 421.66M	47.06M	2025-12
Roche Holding	CHF 22.09B	10.04B	2025-12
Standard Biotools	USD 9.48M	1.15M	2025-09
Thermo Fisher Scientific	USD 4.64B	419M	2025-12
Waters	USD 557.42M	97.44M	2025-12

Illumina Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.